Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. ADBE
6. CHWY
7. NAVN
8. NVDA
9. CRWV
10. CME

Go back to Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance

Tandem Diabetes Care (TNDM) PT Lowered to $51 at Barclays

August 7, 2025 8:27 AM EDT

Barclays analyst Matt Miksic lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $51.00 (from $53.00) while maintaining a Overweight rating.

The analyst comments "Q2 sales were a touch above consensus, with upside OUS offset by a shortfall in the U.S. Mgmt... More